Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 16603
Country/Region: Uganda
Year: 2012
Main Partner: Joint Medical Store
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: USAID
Total Funding: $2,567,899

This Blanket Purchase Agreement (BPA) enables USAID/Uganda to contract with any one of three pre-qualified local pharmaceutical wholesalers to procure, ship, clear, and store a standard basket of quality pharmaceutical products and consumables required to supplement the disposable male circumcision (MC) kits that are currently procured through the SCMS mechanism. The commodities are for use by USAID implementing partners (IPs) providing MC services as part of PEPFAR support to the national HIV/AIDS program. The commodities include anesthetics, reusable surgical instruments for the dorsal slit procedure, consumables like surgical gloves and extra sutures and sterilization drums. Products falling under the ADS 312 on restricted pharmaceutical procurement receive prior USAID/W approval. The BPA is planned to cover the period May 2012 through May 2014 (if funds are sufficient) for a total estimated cost of $2,567,899.

Funding for Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC): $2,567,899

To support the Government of Ugandas national HIV/AIDS prevention program, USAID/Uganda IPs will be carrying out 358,487 VMMC procedures among eligible men during the COP12 period. The purpose of the BPA is to provide USAID IPs with easy, reliable access to quality-assured pharmaceutical products and consumables at standardized prices. Three pharmaceutical wholesalers with requisite capacity and experience were identified through a market survey. Contracting one or more pre-qualified local pharmaceutical suppliers to provide a standard basket of commodities enables the Mission to control product quality, reduce cost through bulk procurement and gain efficiencies by relieving IPs from the time-consuming task of procurement. This arrangement should also eliminate the difficulties IPs have experienced in finding sufficient quantities of some products on the local market. If SCMS is able to contract with MC kit manufacturers to produce a disposable kit for the dorsal slit procedure, in quantities sufficient for the Uganda program, then items such as the surgical instruments needed to make the current disposable kit suitable for dorsal slit will no longer need to be procured. The BPA mechanism has been made flexible enough to include any new product items that may be required for the MC program as it is scaled-up and rolled-out through various models.